InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

MiniMed Group, Inc.

MMED Clue Score44
United States Fiscal year ends December CIK 0002062583
$19.71 -0.45% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $19.71 +42.83% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 6 Mar 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue2,469.0Operating income−69.0Net income−112.0EPS, diluted−0.44Fiscal year 2025Revenue2,715.0 +10.0%Operating income−146.0Net income−213.0EPS, diluted−0.84Fiscal year 2026Revenue3,102.0 +14.3%Operating income−190.0Net income−333.0EPS, diluted−1.30
FY2024FY2025FY2026
Revenue 2,469.0 2,715.0 3,102.0
Growth +10.0% +14.3%
Operating income −69.0 −146.0 −190.0
Net income −112.0 −213.0 −333.0
Growth
EPS, diluted −0.44 −0.84 −1.30
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2024Gross margin58.2%Operating margin−2.8%Net margin−4.5%Free cash flow margin−4.3%Fiscal year 2025Gross margin56.3%Operating margin−5.4%Net margin−7.8%Free cash flow margin−2.0%Fiscal year 2026Gross margin54.2%Operating margin−6.1%Net margin−10.7%Free cash flow margin−13.5%
FY2024FY2025FY2026
Gross margin 58.2% 56.3% 54.2%
Operating margin −2.8% −5.4% −6.1%
Net margin −4.5% −7.8% −10.7%
Free cash flow margin −4.3% −2.0% −13.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow41.0Capital expenditure−148.0Free cash flow−107.0Fiscal year 2025Operating cash flow140.0Capital expenditure−193.0Free cash flow−53.0Fiscal year 2026Operating cash flow−197.0Capital expenditure−223.0Free cash flow−420.0
FY2024FY2025FY2026
Operating cash flow 41.0 140.0 −197.0
Capital expenditure −148.0 −193.0 −223.0
Free cash flow −107.0 −53.0 −420.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2024Cash54.0Shareholders’ equity3,448.0Fiscal year 2025Cash11.0Shareholders’ equity3,330.0Fiscal year 2026Cash298.0Shareholders’ equity3,611.0
FY2024FY2025FY2026
Cash 54.0 11.0 298.0
Shareholders’ equity 3,448.0 3,330.0 3,611.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending April, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 26 Apr 2024 FY2025 25 Apr 2025 FY2026 24 Apr 2026
Revenue and profit
2,469.0 2,715.0 3,102.0
Growth +10.0% +14.3%
1,032.0 1,187.0 1,422.0
1,436.0 1,528.0 1,680.0
Growth +6.4% +9.9%
1,057.0 1,080.0 1,183.0
−69.0 −146.0 −190.0
Growth
−70.0 −147.0 −189.0
38.0 52.0 128.0
−112.0 −213.0 −333.0
Growth
Per share
−0.44 −0.84 −1.30
−0.44 −0.84 −1.30
Growth
252.8 252.8 256.6
252.8 252.8 256.6
Growth +0.0% +1.5%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 3 of 3 years on file.